These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 15485737

  • 1. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP.
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, Barbash G, White H, Simoons ML, Nelson CL.
    N Engl J Med; 1995 May 25; 332(21):1418-24. PubMed ID: 7723799
    [Abstract] [Full Text] [Related]

  • 3. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
    Massel D.
    Can J Cardiol; 1999 Feb 25; 15(2):173-9. PubMed ID: 10079776
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is the use of t-PA as compared with streptokinase cost effective?
    Armentano R, Favaloro RG.
    N Engl J Med; 1995 Oct 12; 333(15):1009-10. PubMed ID: 7666905
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD, Bronskill S, Goel V.
    Can J Cardiol; 1993 Oct 12; 9(6):553-8. PubMed ID: 8221354
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ].
    Golán L, Simek S, Linhart A, Cahlík T, Palecek T, Lubanda JC, Korínek J, Beran S, Aschermann M.
    Vnitr Lek; 2003 Feb 12; 49(2):97-102. PubMed ID: 12728575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
    Tonkin AM, Eckermann S, White H, Friedlander D, Glasziou P, Magnus P, Kirby A, Mulray S, Denton M, Sallaberger M, Hunt D, Simes J, LIPID Study Group.
    Am Heart J; 2006 Jun 12; 151(6):1305-12. PubMed ID: 16781242
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.